The device company’s orthopedic reconstructive business and extremities business totaled $59.5 million and $50.9 million, respectively. These totals represent a 12.2 percent loss and a 0.8 percent gain, respectively.
More Articles on Orthopedic Devices:
Alphatec Spine 3Q Revenue Drops 1.6%
Amedica Names Jay Moyes to Board of Directors
Globus Medical 3Q Worldwide Sales Reach $94.8M, Up 12.5%
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
